GRI Bio (GRI) Free Cash Flow (2020 - 2026)

GRI Bio's Free Cash Flow history runs 7 years deep, the most recent figure standing at -$3.7 million for Q1 2026.

• In Q1 2026, Free Cash Flow fell 112.27% year-over-year to -$3.7 million; the TTM figure through Mar 2026 stood at -$12.1 million (down 49.01% YoY), while the FY2025 annual figure was -$10.2 million, down 18.33% from the prior year.
• Free Cash Flow for Q1 2026 stood at -$3.7 million, down from -$3.0 million in the prior quarter.
• The five-year high for Free Cash Flow was $2.2 million in Q2 2022, with the low at -$5.6 million in Q4 2023.
• The 5-year median for Free Cash Flow is -$2.1 million (2024), against an average of -$1.9 million.
• The sharpest annual moves came in 2022 and 2023: Free Cash Flow soared 187.24% in 2022, then plunged 948.8% in 2023.
• GRI Bio's Free Cash Flow stood at -$847000.0 in 2022, then sank by 556.43% to -$5.6 million in 2023, then surged by 64.05% to -$2.0 million in 2024, then tumbled by 48.62% to -$3.0 million in 2025, then decreased by 24.03% to -$3.7 million in 2026.
• Business Quant data shows GRI's Free Cash Flow at -$3.7 million in Q1 2026, -$3.0 million in Q4 2025, and -$2.3 million in Q3 2025.